Conference Roundup

Maralixibat response associated with health-related quality of life improvements in ALGS

Children with Alagille syndrome (ALGS) who responded to treatment with maralixibat experienced improvements in health-related quality of life (HRQoL) measures, according to data from a post-hoc analysis of the ICONIC study presented at the North American Society for Pediatric Gastroenterology Hepatology and Nutrition Annual Meeting. In this analysis, 27 patients...